University of California San Francisco

Broering Jenny
Jeanette M. (Jenny) Broering, RN, PhD, MPH

Project Manager
UCSF Center for Surgery in Older Adults
Director of Data Procurement and Quality Assurance
Department of Urology

Address

35 Medical Center Way, #6841
San Francisco, CA 94143
United States

Email: jeanette.broering@ucs�.e�u
Phone: 415-514-0203
Fax: 415-476-5366

ORCID: 0000-0002-7580-8931

Education

Institution Degree Dept or School End Date
University of California Diversity, Equity, and Inclusion Champion Training 2022
Veterans Administration Quality Scholar (VAQS) Fellowship Post-doctoral Fellowship Quality Improvement / Patient Safety 06/2014
University of California, San Francisco PhD Nursing / Health Policy 06/2012
University of California, Berkeley MPH Epidemiology / Biostatistics 05/1992
University of California, San Francisco MS Nursing 06/1985
Saint Louis University BSN Nursing 05/1974

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 66
  1. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
    Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR| | PubMed
  2. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).
    Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM| | PubMed
  3. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.
    Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR| | PubMed
  4. Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test.
    Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P| | PubMed
  5. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments.
    Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C| | PubMed
  6. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
    Cooperberg MR, Vickers AJ, Broering JM, Carroll PR| | PubMed
  7. Time trends and local variation in primary treatment of localized prostate cancer.
    Cooperberg MR, Broering JM, Carroll PR| | PubMed
  8. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression.
    Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM| | PubMed
  9. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
    Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H| | PubMed
  10. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
    Cooperberg MR, Broering JM, Carroll PR| | PubMed
66
View all 66 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 66
  1. Evaluating a digital prehabilitation tool in patients with colorectal surgery: protocol for a multisite randomised controlled trial.
    Ogomori K, Broering J, Rogine C, Kin C, Chang GJ, Finlayson E| | PubMed
  2. Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of a Presurgical Toolkit (OPTI-Surg)-Final Results of a Phase III Cluster Randomized Trial (Alliance A231601CD).
    Chang GJ, Gunn HJ, Barber AK, Lowenstein LM, Dohan D, Broering J, Dockter T, Tan AD, Dueck A, Chow S, Neuman H, Finlayson E, OPTI-Surg Investigators| | PubMed
  3. "It Gives Me Peace of Mind So I Can Focus on Healing": Views on Advance Care Planning for Older Surgical Patients.
    Colley A, Broering J, Lee K, Lin JA, Pierce L, Finlayson E, Sudore RL, Wick EC| | PubMed
  4. The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.
    Braun AE, Chan JM, Neuhaus J, Cowan JE, Kenfield SA, Van Blarigan EL, Tenggara I, Broering JM, Simko JP, Carroll PR, Cooperberg MR| | PubMed
  5. Gender Bias in Letters of Recommendation: Relevance to Urology Match Outcomes and Pursuit of Fellowship Training/Academic Career.
    Nosrat C, Martin-Tuite P, Jiang F, Broering J, Shindel AW| | PubMed
  6. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.
    Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR| | PubMed
  7. Ten-year work burden after prostate cancer treatment.
    Washington SL, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR| | PubMed
  8. Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer.
    Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR| | PubMed
  9. The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer.
    Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR| | PubMed
  10. Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality.
    Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM| | PubMed
  11. Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula.
    Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA| | PubMed
  12. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.
    Weng X, Zhong L, Xiang P, Li Y, Paciorek A, Dong L, Broering J, Carroll PR, Sanda M, Wilson L| | PubMed
  13. See one, do one, teach one: a flipped classroom to make quality improvement experiential in surgical residency
    Bongiovanni, T., Lancaster, E., Decker, H., Mukhtar, R. A., Schwab, M., Broering, J., O’Sullivan, P., Hirose, K., & Wick, E.| | UCSF Research Profile
  14. Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality.
    Langlais CS, Graff RE, Van Blarigan EL, Kenfield SA, Neuhaus J, Tabung FK, Cowan JE, Broering JM, Carroll P, Chan JM| | PubMed
  15. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer.
    Lonergan PE, Washington SL, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR| | PubMed
  16. Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history.
    Langlais CS, Chan JM, Kenfield SA, Cowan JE, Graff RE, Broering JM, Carroll P, Van Blarigan EL| | PubMed
  17. Patient Perceptions on Barriers and Facilitators to Accessing Low-acuity Surgery During COVID-19 Pandemic.
    Johnson CL, Schwartz H, Greenberg A, Hernandez S, Nnamani Silva ON, Wong LE, Martins DB, Broering JM, Kumar SB, Bongiovanni T, Wick EC, Roman SA| | PubMed
  18. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial.
    Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM| | PubMed
  19. Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study.
    Wang EY, Graff RE, Chan JM, Langlais CS, Broering JM, Ramsdill JW, Kessler ER, Winters-Stone KM, Van Blarigan EL, Kenfield SA| | PubMed
  20. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
    Borno HT, Cowan JE, Zhao S, Broering JM, Carroll PR, Ryan CJ| | PubMed
  21. The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer.
    Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR| | PubMed
  22. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.
    Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR| | PubMed
  23. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.
    Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS| | PubMed
  24. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.
    Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM| | PubMed
  25. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.
    Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM| | PubMed
  26. What Matters? The Valued Life Activities of Older Adults Undergoing Elective Surgery.
    Kata A, Dutt M, Sudore RL, Finlayson E, Broering JM, Tang VL| | PubMed
  27. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.
    Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR| | PubMed
  28. Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor.
    Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR| | PubMed
  29. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial.
    Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM| | PubMed
  30. Increasing Advance Care Planning Using a Surgical Optimization Program for Older Adults.
    Kata A, Sudore R, Finlayson E, Broering JM, Ngo S, Tang VL| | PubMed
  31. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
    Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR| | PubMed
  32. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).
    Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM| | PubMed
  33. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.
    Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR| | PubMed
  34. Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test.
    Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P| | PubMed
  35. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments.
    Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C| | PubMed
  36. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
    Cooperberg MR, Vickers AJ, Broering JM, Carroll PR| | PubMed
  37. Time trends and local variation in primary treatment of localized prostate cancer.
    Cooperberg MR, Broering JM, Carroll PR| | PubMed
  38. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression.
    Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM| | PubMed
  39. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
    Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H| | PubMed
  40. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
    Cooperberg MR, Broering JM, Carroll PR| | PubMed
  41. High-risk prostate cancer in the United States, 1990-2007.
    Cooperberg MR, Cowan J, Broering JM, Carroll PR| | PubMed
  42. Contemporary trends in low risk prostate cancer: risk assessment and treatment.
    Cooperberg MR, Broering JM, Kantoff PW, Carroll PR| | PubMed
  43. Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice.
    Litwin MS, Greenfield S, Elkin EP, Lubeck DP, Broering JM, Kaplan SH| | PubMed
  44. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR| | PubMed
  45. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE.
    Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR| | PubMed
  46. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
    Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR| | PubMed
  47. Regression of low-grade squamous intra-epithelial lesions in young women.
    Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, Miller S, Canjura-Clayton KL, Farhat S, Broering JM, Darragh TM| | PubMed
  48. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management.
    Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR| | PubMed
  49. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
    Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR, CaPSURE Investigators| | PubMed
  50. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR| | PubMed
  51. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.
    Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR| | PubMed
  52. Patient satisfaction with oral versus nonoral therapeutic approaches in onychomycosis.
    Stier DM, Gause D, Joseph WS, Schein JR, Broering JM, Warolin KL, Doyle JJ| | PubMed
  53. Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy.
    Grossfeld GD, Small EJ, Lubeck DP, Latini D, Broering JM, Carroll PR| | PubMed
  54. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.
    Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J| | PubMed
  55. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
    Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll PR| | PubMed
  56. Cost of treatment for onychomycosis. Data from a 9-month observational study.
    Stier DM, Henke C, Schein J, Doyle J, Schonfeld WH, Broering J| | PubMed
  57. Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database.
    Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Carroll PR| | PubMed
  58. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.
    Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR| | PubMed
  59. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
    Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll PR| | PubMed
  60. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.
    Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, Palefsky J| | PubMed
  61. Female adolescents at high, moderate, and low risk of exposure to HIV: differences in knowledge, beliefs, and behavior.
    Millstein SG, Moscicki AB, Broering JM| | PubMed
  62. Risks of human immunodeficiency virus infection among adolescents attending three diverse clinics.
    Moscicki AB, Millstein SG, Broering J, Irwin CE| | PubMed
  63. Comparison between colposcopic, cytologic, and histologic findings in women positive and negative for human papillomavirus DNA.
    Moscicki AB, Broering J, Powell K, Klein J, Clayton L, Smith G, Boero S, Darragh TM, Brescia RJ, Palefsky J| | PubMed
  64. Childhood sexual learning and sex education in schools.
    Broering JM| | PubMed
  65. Adolescent health care: a challenge for nursing educators.
    Panzarine S, Broering J, Gephart J, Lucas SE, Minas E, Savedra M, St Germaine A, Wildey L| | PubMed
  66. Juvenile Status Offenders' Perceptions of Life Change Events
    Broering JM
    Irwin CE    | | UCSF Research Profile